VT1021 is a cyclic peptide that inhibits tumor growth by inducing the anti-angiogenic factor thrombospondin-1 (TSP-1) in myeloid-derived suppressor cells (MDSCs), thereby promoting TME modulation by simultaneously targeting CD36 and CD47[60]. Here, CD36 is linked to neoplasm.